OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Doxorubicin prodrug-based nanomedicines for the treatment of cancer
Haibo Zhao, Jing Yu, Renshuai Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115612-115612
Closed Access | Times Cited: 50
Haibo Zhao, Jing Yu, Renshuai Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115612-115612
Closed Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Nanomaterials-based advanced systems for photothermal / photodynamic therapy of oral cancer
Yue Wang, Lili Chang, Hongyu Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116508-116508
Closed Access | Times Cited: 15
Yue Wang, Lili Chang, Hongyu Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116508-116508
Closed Access | Times Cited: 15
Rnd3 protects against doxorubicin-induced cardiotoxicity through inhibition of PANoptosis in a Rock1/Drp1/mitochondrial fission-dependent manner
Ge Wen, Xiaohua Zhang, Jie Lin, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Ge Wen, Xiaohua Zhang, Jie Lin, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review
Renshuai Zhang, Xiaohua Zhao, Ang Jia, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125993-125993
Closed Access | Times Cited: 29
Renshuai Zhang, Xiaohua Zhao, Ang Jia, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125993-125993
Closed Access | Times Cited: 29
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment
Natalia I. Agalakova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 945-945
Open Access | Times Cited: 13
Natalia I. Agalakova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 945-945
Open Access | Times Cited: 13
Novel drug delivery systems: Insight into self-powered and nano-enabled drug delivery systems
Ugochi E. Ewii, Adaeze Linda Onugwu, Victor C. Nwokpor, et al.
Nano TransMed (2024) Vol. 3, pp. 100042-100042
Open Access | Times Cited: 11
Ugochi E. Ewii, Adaeze Linda Onugwu, Victor C. Nwokpor, et al.
Nano TransMed (2024) Vol. 3, pp. 100042-100042
Open Access | Times Cited: 11
Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects
Bin Wang, Wanpeng Yu, Hongfei Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Bin Wang, Wanpeng Yu, Hongfei Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Nanozyme-based synergistic therapeutic strategies against tumors
Ye Zhang, Ning Zhang, Shouping Gong, et al.
Drug Discovery Today (2025), pp. 104292-104292
Closed Access | Times Cited: 1
Ye Zhang, Ning Zhang, Shouping Gong, et al.
Drug Discovery Today (2025), pp. 104292-104292
Closed Access | Times Cited: 1
Camptothecin-based prodrug nanomedicines for cancer therapy
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment
Yuxuan Tu, Jianbao Gong, Jing Mou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Yuxuan Tu, Jianbao Gong, Jing Mou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
NOX4 aggravates doxorubicin-induced cardiomyocyte pyroptosis by increasing reactive oxygen species content and activating the NLRP3 inflammasome
Hong Zeng, Pengtao Zou, Yanmei Chen, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 84-100
Open Access | Times Cited: 6
Hong Zeng, Pengtao Zou, Yanmei Chen, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 84-100
Open Access | Times Cited: 6
Acid-sensitive prodrugs; a promising approach for site-specific and targeted drug release
Adila Nazli, Muhammad Zafar Irshad Khan, Ákos Rácz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116699-116699
Open Access | Times Cited: 6
Adila Nazli, Muhammad Zafar Irshad Khan, Ákos Rácz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116699-116699
Open Access | Times Cited: 6
An Unusual Application of Multifunctional Nanozyme Derived from COF: Augmenting Chemoimmunotherapy while Attenuating Cardiotoxicity
Wenxin Lv, Guangwei Jiang, Xiaojun Lin, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 6
Wenxin Lv, Guangwei Jiang, Xiaojun Lin, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 6
Proteolysis-Targeting Chimera-Doxorubicin Conjugate Nanoassemblies for Dual Treatment of EGFR-TKI Sensitive and Resistant Non-Small Cell Lung Cancer
Junhui Ma, Ruixue Zhu, Meijing Li, et al.
Acta Biomaterialia (2025)
Closed Access
Junhui Ma, Ruixue Zhu, Meijing Li, et al.
Acta Biomaterialia (2025)
Closed Access
Marine Natural Products in Inflammation‐Related Diseases: Opportunities and Challenges
Tao Zhang, Zijun Ouyang, Yueran Zhang, et al.
Medicinal Research Reviews (2025)
Closed Access
Tao Zhang, Zijun Ouyang, Yueran Zhang, et al.
Medicinal Research Reviews (2025)
Closed Access
Liposomes and Niosomes: New trends and applications in the delivery of bioactive agents for cancer therapy
Helena de Almeida Cerqueira Kodel, Paria Alizadeh, Samad Nejad Ebrahimi, et al.
International Journal of Pharmaceutics (2024), pp. 124994-124994
Closed Access | Times Cited: 4
Helena de Almeida Cerqueira Kodel, Paria Alizadeh, Samad Nejad Ebrahimi, et al.
International Journal of Pharmaceutics (2024), pp. 124994-124994
Closed Access | Times Cited: 4
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
Dianying Zhang, Jingjing Zhao, Yujing Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Dianying Zhang, Jingjing Zhao, Yujing Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Protection of Bortezomib Via Beta-Hydroxy Ketone Skeleton in Doxorubicin and the Interaction with Bovine Serum Albumin: Spectroscopic and Molecular Docking Studies
Shan Qiao, Yun S. Song, Dong Xu, et al.
(2025)
Closed Access
Shan Qiao, Yun S. Song, Dong Xu, et al.
(2025)
Closed Access
Atom-efficient and self-delivered prodrug based on methylene blue and doxorubicin for tumor combination therapy
Yuchen Song, Qiang Wang, Qiankun Shi, et al.
Dyes and Pigments (2025), pp. 112699-112699
Closed Access
Yuchen Song, Qiang Wang, Qiankun Shi, et al.
Dyes and Pigments (2025), pp. 112699-112699
Closed Access
Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Advances in chemically modified HSA as a multifunctional carrier for transforming cancer therapy regimens
Zheng Sun, Hui Fu, Ruixuan Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 305, pp. 141373-141373
Closed Access
Zheng Sun, Hui Fu, Ruixuan Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 305, pp. 141373-141373
Closed Access
Recent advances in microfluidic-based photoelectrochemical (PEC) sensing platforms for biomedical applications
Zaman Abdalhussein Ibadi Alaridhee, Mohammed B. Alqaraguly, Shoira Formanova, et al.
Microchimica Acta (2025) Vol. 192, Iss. 5
Closed Access
Zaman Abdalhussein Ibadi Alaridhee, Mohammed B. Alqaraguly, Shoira Formanova, et al.
Microchimica Acta (2025) Vol. 192, Iss. 5
Closed Access
Stimuli-Responsive Prodrugs with Self-Immolative Linker for Improved Cancer Therapy
Xu Wenting, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116928-116928
Closed Access | Times Cited: 3
Xu Wenting, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116928-116928
Closed Access | Times Cited: 3
Protective Effects of Thymoquinone on Doxorubicin-induced Lipid Peroxidation and Antioxidant Enzyme Levels in Rat Peripheral Tissues
Deniz Akpınar, Tanju Mercan, Halit Demir, et al.
Pakistan Veterinary Journal (2023)
Open Access | Times Cited: 8
Deniz Akpınar, Tanju Mercan, Halit Demir, et al.
Pakistan Veterinary Journal (2023)
Open Access | Times Cited: 8
Glutathione‐triggered prodrugs: Design strategies, potential applications, and perspectives
Jintao Zhao, Xinming Li, Tao Ma, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1013-1054
Closed Access | Times Cited: 8
Jintao Zhao, Xinming Li, Tao Ma, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1013-1054
Closed Access | Times Cited: 8
Transformable binary-prodrug nanoparticles harness heterogeneity of neutrophils to overcome multidrug resistance and promote pyroptosis in cancer
Dezhi Sui, Kaituo Zhang, Zhaowei Qi, et al.
Applied Materials Today (2024) Vol. 37, pp. 102110-102110
Closed Access | Times Cited: 2
Dezhi Sui, Kaituo Zhang, Zhaowei Qi, et al.
Applied Materials Today (2024) Vol. 37, pp. 102110-102110
Closed Access | Times Cited: 2
